299203-94-4

Usage

Uses

Used in Pharmaceutical Research:
2-(4-([(TERT-BUTOXY)CARBONYL]AMINO)PIPERIDIN-1-YL)ACETIC ACID is used as a building block for the development of new drugs, leveraging its piperidine derivative structure and the protective Boc group for selective reactions.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 2-(4-([(TERT-BUTOXY)CARBONYL]AMINO)PIPERIDIN-1-YL)ACETIC ACID is utilized for its potential to contribute to the synthesis of bioactive compounds, with the Boc group facilitating controlled organic synthesis processes.
Used in Organic Synthesis:
2-(4-([(TERT-BUTOXY)CARBONYL]AMINO)PIPERIDIN-1-YL)ACETIC ACID is used as a protected amino compound for selective organic synthesis, where the Boc group ensures that the amino group remains intact during certain reaction conditions.
Used in Drug Development:
In the industry of drug development, 2-(4-([(TERT-BUTOXY)CARBONYL]AMINO)PIPERIDIN-1-YL)ACETIC ACID is employed as a precursor in the synthesis of pharmaceuticals, taking advantage of its unique structure to create novel therapeutic agents.

Upstream product

• 203662-91-3 4-[(tert-butyloxycarbonyl)amino]-1-[(ethoxycarbonyl)methyl]piperidine 
• 73874-95-0 (piperidin-4-yl)carbamic acid tert-butyl ester 

Relevant academic research and scientific papers

TERTIARY AMINES, MEDICAMENTS CONTAINING SAID AMINES, USE THEREOF AND PROCESSES FOR THE PREPARATION THEREOF

The present invention relates to compounds of general formula (I), and the tautomers and the salts thereof, particularly the pharmaceutically acceptable salts thereof with inorganic or organic acids and bases, which have valuable pharmacological properties, particularly an inhibitory effect on epithelial sodium channels, the use thereof for the treatment of diseases, particularly diseases of the lungs and airways.

TERTIARY AMINES, MEDICAMENTS CONTAINING SAID AMINES, USE THEREOF AND PROCESSES FOR THE PREPARATION THEREOF

The present invention relates to compounds of general formula (I) and the tautomers and the salts thereof, particularly the pharmaceutically acceptable salts thereof with inorganic or organic acids and bases, which have valuable pharmacological properties, particularly an inhibitory effect on epithelial sodium channels, the use thereof for the treatment of diseases, particularly diseases of the lungs and airways.

BASIC GROUP-CONTAINING COMPOUND AND USE THEREOF

A compound represented by general formula (I): a salt thereof, a solvate thereof, or a prodrug thereof wherein all symbols are as defined in the specification has an antagonistic activity against CXCR4 and is therefore useful as a preventive and/or therap